whats a protocol for bpc 157

There isn’t one established BPC-157 protocol. One commonly described regimen is 300–500 micrograms injected subcutaneously or intramuscularly, two to three times per week, sometimes up to five days per week. One account describes an eight-week course followed by an eight-to-ten-week break, but this is a reported practice—not a proven standard. 1 2

• Use the minimum effective amount; avoid continuous use. The discussion specifically cautions against daily, indefinite use and recommends monitoring for unintended effects. 3
• Potential risks: BPC-157 may increase blood-vessel growth and upregulate growth-hormone receptors around an injury; the discussion raises concern that these effects could potentially support tumor growth. 4
• Evidence is limited: Much of the research is in animals, while human evidence is sparse and includes anecdotal reports. The discussion emphasizes the uncertainty and advises working with a physician about use and dosing. 5 6

These are reported practices, not a personalized medical recommendation.